BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26820712)

  • 1. Aberrant expression of Golgi protein 73 is indicative of a poor outcome in hepatocellular carcinoma.
    Jiang K; Li W; Shang S; Sun L; Guo K; Zhang S; Liu Y
    Oncol Rep; 2016 Apr; 35(4):2141-50. PubMed ID: 26820712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of GP73 inhibits invasion and metastasis via suppression of epithelial-mesenchymal transition in hepatocellular carcinoma.
    Yang Y; Liu Q; Zhang H; Zhao H; Mao R; Li Z; Ya S; Jia C; Bao Y
    Oncol Rep; 2017 Feb; 37(2):1182-1188. PubMed ID: 28075476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.
    Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H
    Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
    Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of Golgi phosphoprotein 2 inhibits hepatocellular carcinoma cell proliferation and motility.
    Liu Y; Zhang X; Sun T; Jiang J; Li Y; Chen M; Wei Z; Jiang W; Zhou L
    Oncotarget; 2016 Apr; 7(16):21404-15. PubMed ID: 26870893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Golgi protein 73 activation of MMP-13 promotes hepatocellular carcinoma cell invasion.
    Jin D; Tao J; Li D; Wang Y; Li L; Hu Z; Zhou Z; Chang X; Qu C; Zhang H
    Oncotarget; 2015 Oct; 6(32):33523-33. PubMed ID: 26378022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic significance of golgiglycoprotein73 (GP73) with epithelial-mesenchymal transition (EMT) related molecules in hepatocellular carcinoma (HCC).
    Bao YX; Cao Q; Yang Y; Mao R; Xiao L; Zhang H; Zhao HR; Wen H
    Diagn Pathol; 2013 Dec; 8():197. PubMed ID: 24313979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Du R; Wu S; Lv X; Fang H; Wu S; Kang J
    J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic expression of hepatic GP73 mRNA and protein and circulating GP73 during hepatocytes malignant transformation.
    Sai WL; Yao M; Shen SJ; Zheng WJ; Sun JY; Wu MN; Wang L; Yao DF
    Hepatobiliary Pancreat Dis Int; 2020 Oct; 19(5):449-454. PubMed ID: 32171652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-559 targets GP73 to suppress proliferation and invasion of hepatocellular carcinoma in vitro.
    Zheng XS; Liu HJ; Zhang LL; Li H; Wang CJ; Xin YJ; Hao R
    Kaohsiung J Med Sci; 2020 Oct; 36(10):793-798. PubMed ID: 32492286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIN1 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition.
    Xu J; Li X; Yang H; Chang R; Kong C; Yang L
    Cancer; 2013 Jun; 119(12):2247-57. PubMed ID: 23564492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
    Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
    Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological significance of miR-27b targeting Golgi protein 73 in patients with hepatocellular carcinoma.
    Liang H; Ai-Jun J; Ji-Zong Z; Jian-Bo H; Liang Z; Yong-Xiang Y; Chen Y
    Anticancer Drugs; 2019 Feb; 30(2):186-194. PubMed ID: 30418194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
    Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
    Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The response of Golgi protein 73 to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma may relate to the influence of certain chemotherapeutics.
    Pan J; Zhang YF; Yang HY; Xu HF; Lu X; Sang XT; Zhong SX; Mao YL
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):406-12. PubMed ID: 26256086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Golgi protein 73 expression in hepatocellular carcinoma tissue correlates with tumor aggression but not survival.
    Sun Y; Yang H; Mao Y; Xu H; Zhang J; Li G; Lu X; Sang X; Zhao H; Zhong S; Huang J; Zhang H
    J Gastroenterol Hepatol; 2011 Jul; 26(7):1207-12. PubMed ID: 21443671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of GP73 promotes cell invasion, migration and metastasis by inducing epithelial-mesenchymal transition in pancreatic cancer.
    Song YX; Xu ZC; Li HL; Yang PL; Du JK; Xu J
    Pancreatology; 2018 Oct; 18(7):812-821. PubMed ID: 30217697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of Golgi phosphoprotein 73 blocks the trafficking of matrix metalloproteinase-2 in hepatocellular carcinoma cells and inhibits cell invasion.
    Liu Y; Zhang X; Zhou S; Shi J; Xu Y; He J; Lin F; Wei A; Zhou L; Chen Z
    J Cell Mol Med; 2019 Apr; 23(4):2399-2409. PubMed ID: 30677226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embryonic morphogen nodal is associated with progression and poor prognosis of hepatocellular carcinoma.
    Chen J; Liu WB; Jia WD; Xu GL; Ma JL; Ren Y; Chen H; Sun SN; Huang M; Li JS
    PLoS One; 2014; 9(1):e85840. PubMed ID: 24465741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.